Indoleamine 2,3-dioxygenase and regulatory dendritic cells contribute to the allograft protection induced by infusion of donor-specific splenic stromal cells
Indoleamine 2,3-dioxygenase and regulatory dendritic cells contribute to the allograft protection induced by infusion of donor-specific splenic stromal cells
复制标题
吲哚胺2,3-双加氧酶和调节性树突状细胞有助于输注供体特异性脾基质细胞诱导的同种异体移植物保护
DOI:
10.1038/cmi.2010.53
复制
发表时间:
2011
期刊:
影响因子:
--
通讯作者:
Gong, Feili
中科院分区:
文献类型:
--
作者:
Fang, Min;Duan, Lihua;Gong, Min;Dai, Hong;Gong, Quan;Zheng, Fang;Tan, Zheng;Wang, Congyi;Gong, Feili
It has been reported that splenic stromal cells (SSCs) are capable of directly supporting the development of CD11c(lo)CD45RB(+ )IL-10-producing dendritic cells (DCs) from lineage-negative c-kit(+) progenitor cells in the absence of exogenous cytokines. In vitro, DCs that differentiate on stromal cells suppress mixed leukocyte reaction responses and induce primary alloreactive CD4(+) T cells to differentiate into IL-10-producing Tr1 cells. However, the precise mechanisms by which these SSCs exert their regulatory functions in vivo remain undefined. Furthermore, their possible contribution to the development of allograft transplantation tolerance has yet to be examined. Here, we have used both murine skin and cardiac allograft transplantation models to explore whether in vivo alloresponses can be regulated by infusion with donor-derived SSCs and to investigate the possible mechanisms by which SSCs exert regulatory effects to prevent allograft rejection. We show that intravenous SSC infusion prolonged murine skin allograft survival. The prolonged graft survival is associated with augmentation of the generation of regulatory DC subsets and CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs), as well as upregulation of the production of suppressive cytokines IL-10 and transforming growth factor (TGF)-β. Moreover, we found that indoleamine 2,3-dioxygenase and SSC-derived regulatory DCs contribute to allograft protection by infusion of donor-specific SSCs. Our data suggest that donor-derived SSCs could be used as a therapeutic target to promote transplantation tolerance.
登录
查看更多内容
影响因子:
32.4
作者:
Svensson, M;Maroof, A;Kaye, PM
通讯作者:
Kaye, PM
DOI:
10.1084/jem.194.6.769
发表时间:
2001-09-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Hawiger D;Inaba K;Dorsett Y;Guo M;Mahnke K;Rivera M;Ravetch JV;Steinman RM;Nussenzweig MC
通讯作者:
Nussenzweig MC
影响因子:
4.4
作者:
Haniffa, Muzlifah A.;Wang, Xiao-Nong;Collin, Matthew P.
通讯作者:
Collin, Matthew P.
影响因子:
20.3
作者:
Meisel, R;Zibert, A;Dilloo, D
通讯作者:
Dilloo, D
影响因子:
15.3
作者:
Belz, Gabrielle T;Behrens, Georg M N;Smith, Chris M;Miller, Jacques F A P;Jones, Claerwen;Lejon, Kristina;Fathman, C Garrison;Mueller, Scott N;Shortman, Ken;Carbone, Francis R;Heath, William R
通讯作者:
Heath, William R